BioVersys AG | WebDisclosure

Basculer en Français

8714	Companies
152606	Keywords
88230	Articles
82021	Press releases

Home
Companies
BioVersys AG

BRIEF

published on 03/31/2025 at 07:05, 2 months 14 days ago

BioVersys Secures Chinese Patent for BV100 Technology

Chinese Market BioVersys AG BV100 Patent Acinetobacter Infections Rifabutin Formulation
PRESS RELEASE

published on 03/31/2025 at 07:00, 2 months 14 days ago

BIOVERSYS ANNOUNCES IMPORTANT BV100 PATENT GRANTED BY CHINESE PATENT OFFICE
BioVersys AG announces the granting of an important BV100 patent by the Chinese Patent Office, protecting novel drug candidate technology

Patent China BioVersys AG BV100 Antibacterial
BRIEF

published on 03/26/2025 at 07:05, 2 months 19 days ago

BioVersys présente ses réalisations et ses résultats financiers pour 2024

Résultats Financiers 2024 Succès De L'introduction En Bourse BioVersys AG Essai BV100 Études Sur L'Alpibectir
BRIEF

published on 03/26/2025 at 07:05, 2 months 19 days ago

BioVersys Outlines 2024 Achievements and Financials

2024 Financials IPO Success BioVersys AG BV100 Trial Alpibectir Studies
PRESS RELEASE

published on 03/26/2025 at 07:00, 2 months 19 days ago

BIOVERSYS REPORTS CORPORATE HIGHLIGHS AND KEY FINANCIALS FOR THE FULL YEAR 2024
BioVersys AG reports corporate highlights and key financials for the full year 2024 including successful IPO on SIX Swiss Exchange, Phase 2 trial results, and financial activities

Financial Results Clinical Trials IPO Operating Income BioVersys AG
BRIEF

published on 03/19/2025 at 07:05, 2 months 26 days ago

First Patient Dosed in Alpibectir-Ethionamide TB Trial

Phase 2 Trial GSK Collaboration BioVersys Alpibectir-Ethionamide Tuberculosis
BRIEF

published on 03/19/2025 at 07:05, 2 months 26 days ago

Premier patient traité dans le cadre de l'essai Alpibectir-Éthionamide contre la tuberculose

Essai De Phase 2 Collaboration GSK BioVersys Alpibectir-Ethionamide Tuberculose
PRESS RELEASE

published on 03/19/2025 at 07:00, 2 months 26 days ago

FIRST EVER PATIENT DOSED WITH ALPIBECTIR-ETHIONAMIDE IN COMBINATION WITH FIRST-LINE TB DRUGS IN A 14-DAY PHASE 2 CLINICAL TRIAL
First patient dosed in 14-day Phase 2 clinical trial evaluating Alpibectir-Ethionamide with first-line TB drugs under BioVersys and GSK collaboration for pulmonary TB patients

GSK Phase 2 BioVersys Alpibectir-Ethionamide TB
BRIEF

published on 03/14/2025 at 07:05, 3 months ago

BioVersys annonce la publication de ses résultats financiers pour l'exercice 2024 au 26 mars

Résultats Financiers Biopharmaceutique Conférence Téléphonique Produits Antibactériens BioVersys
BRIEF

published on 03/14/2025 at 07:05, 3 months ago

BioVersys Sets March 26 for Full-Year 2024 Financial Results Release

Financial Results Conference Call Biopharmaceutical Antibacterial Products BioVersys

Accesswire

Published on 06/14/2025 at 16:25, 6 hours 31 minutes ago

New to The Street Episode #671 Airs Tonight on Bloomberg Television at 6:30 PM EST Featuring FLOKI, Arrive AI (NASDAQ: ARAI), Health In Tech (NASDAQ: HIT), Vita Bella, and NRX Pharmaceuticals (NASDAQ: NRXP)
Published on 06/14/2025 at 02:00, 20 hours 56 minutes ago

Battery X Metals Validates Provisional Patent Applications Filed with the United States Patent and Trademark Office Through Successful Real-World Trials of Next-Generation Lithium-Ion Battery Rebalancing Machine
Published on 06/14/2025 at 01:52, 21 hours 4 minutes ago

Avino Renews ATM Equity Program
Published on 06/14/2025 at 01:05, 21 hours 51 minutes ago

Diamcor Receives Section 244 Notice from Tiffany & Co.
Published on 06/14/2025 at 00:15, 22 hours 41 minutes ago

Carbeeza Announces Settlement Agreement

View all ACCESSWIRE

EQS Group

Published on 06/13/2025 at 19:10, 1 day 3 hours ago

Allane Mobility Group records growth in operating business in 2024
Published on 06/13/2025 at 18:47, 1 day 4 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/13/2025 at 18:47, 1 day 4 hours ago

Funding Circle Holdings plc: HOL-Holdings in Company - AMENDED
Published on 06/13/2025 at 18:42, 1 day 4 hours ago

Funding Circle Holdings plc: HOL-Holdings in Company - AMENDED
Published on 06/13/2025 at 18:00, 1 day 4 hours ago

BOA CONCEPT: Mise à disposition des documents préparatoires de l’Assemblée Générale du 26 juin 2025

Les Echos

Published on 06/13/2025 at 18:07, 1 day 4 hours ago

Déclaration des transactions sur actions propres réalisées du 2 juin au 6 juin 2025
Published on 06/13/2025 at 18:07, 1 day 4 hours ago

Disclosure of trading in own shares between June 2nd and 6th, 2025
Published on 06/13/2025 at 17:45, 1 day 5 hours ago

STEF : Droits de vote au 31-05-2025
Published on 06/13/2025 at 09:55, 1 day 13 hours ago

Déclaration d'actions et de droits de vote au 31.05.2025
Published on 06/13/2025 at 09:33, 1 day 13 hours ago

Combined General Meeting, June 12, 2025

View all LES ECHOS COMFI WIRE